During the past decade, Rochester Institute for Digestive Diseases conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rochester Institute for Digestive Diseases" #1 sponsor was "Abbott" with 3 trials, followed by "Mesoblast, Inc." with 2 trials sponsored, "Synta Pharmaceuticals Corp." with 2 trials sponsored, "Biogen" with 1 trials sponsored and "Ionis Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rochester Institute for Digestive Diseases" #1 collaborator was "Elan Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rochester Institute for Digestive Diseases" are "Crohn's Disease" (8 trials) and "Hepatitis C, Chronic" (1 trials). Many other conditions were trialed in "Rochester Institute for Digestive Diseases" in a lesser frequency.

Most popular intervention types in "Rochester Institute for Digestive Diseases" are "Drug" (7 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Adalimumab (D2E7)" (1 trials), "Adalimumab 40 mg eow or ew" (1 trials), "DB adalimumab 40 mg eow" (1 trials) and "DB adalimumab 40 mg ew" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rochester Institute for Digestive Diseases" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Rochester Institute for Digestive Diseases". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Rochester Institute for Digestive Diseases, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rochester Institute for Digestive Diseases, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".